Low-Level Laser Therapy in Chronic Autoimmune Thyroiditis
Brazil43 participantsStarted 2006-03
Plain-language summary
The purpose of this study is to evaluate whether low-level Laser therapy is effective in ameliorating the thyroid function of patients with hypothyroidism caused by chronic autoimmune thyroiditis.
Who can participate
Age range20 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients previously diagnosed with hypothyroidism induced by chronic autoimmune thyroiditis (CAT). The presence of hypothyroidism, laboratory measurements and ultrasonography criteria were applied to diagnose CAT.
* Significantly elevated concentrations of thyroid peroxidase (TPOAb) and/or thyroglobulin (TgAb) autoantibodies
* Ultrasonography results consistent with CAT
* Patients undergoing LT4 treatment
* Normal (or almost normal) levels of triiodothyronine (T3), thyroxine (T4), free T4 and thyrotropin (TSH)
Exclusion Criteria:
* Use of immunosuppressants, immunostimulants, or other drugs that could interfere with the production, metabolism and transport of thyroid hormones
* CAT with normal thyroid function
* CAT with subclinical hypothyroidism
* Thyroid nodules
* Hypothyroidism stemming from post-partum thyroiditis (up to 18 months after gestation)
* History of Graves' disease
* Thyrotropin receptor antibody (TRAb) detectable
* Prior treatment with radioiodine
* Tracheal stenosis
* Pregnancy
* History of ionizing irradiation and/or neoplasia in the cervical area
* Previous surgical intervention in the thyroid
* Thyroid hypoplasia
* Ectopic thyroid
* Serious illness (cancer, ischemic coronary artery disease, stroke, kidney or liver failure, etc.)
What they're measuring
1
The main outcome measure was to gauge the effectiveness of applying LLLT in patients with hypothyroidism caused by CAT evaluated by a significant reduction of the levothyroxine (LT4) mean dose (µ/day) 9 months post-LT4 withdrawal.
Timeframe: LT4 dose, concentrations of T3, T4, free T4 and TSH were evaluated and compared before intervention and 9 months post-LT4 withdrawal.